Chronic Kidney Disease(CKD): Clinical Trials

3 trials for Chronic Kidney Disease(CKD), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 completed. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Recruiting 2, Completed 1

Follow Chronic Kidney Disease(CKD): new trials by email Literature Review of Chronic Kidney Disease(CKD) trials Research Report on Chronic Kidney Disease(CKD)

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disease
Dapagliflozin, Semaglutide, Finerenone - Chronic Kidney Disease(CKD)
Phase 4RecruitingPeter Rossing1252025-06-202025-11-20
Calcium-Phosphorus Regulation Therapy on Heart Valve Disease
Sevelamer, Calcium carbonate - Degenerative Heart Valve Disease, Heart Valve Calcification
Phase 4RecruitingChina National Center for Cardiovascular Diseases1962024-03-012024-10-28
Compare Efficacy/Safety of Repeat Doses of Ferumoxytol With Iron Sucrose in CKD Subjects With IDA and on Hemodialysis
Ferumoxytol, Iron Sucrose - Iron Deficiency Anemia Treatment, Chronic Kidney Disease(CKD)
Phase 4CompletedAMAG Pharmaceuticals, Inc.2962013-08-012022-04-21

Narrower conditions

Renal Insufficiency, Chronic (3)  ·  Anemia, Iron-Deficiency (1)

Broader conditions

Chronic Disease (3)  ·  Disease Attributes (3)  ·  Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Kidney Diseases (3)  ·  Male Urogenital Diseases (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Renal Insufficiency (3)  ·  Urogenital Diseases (3)  ·  Urologic Diseases (3)  ·  Anemia (1)  ·  Anemia, Hypochromic (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)

Interventions

Calcium Carbonate (1)  ·  Ferric Oxide, Saccharated (1)  ·  Ferrosoferric Oxide (1)  ·  Sevelamer (1)  ·  dapagliflozin (1)  ·  finerenone (1)  ·  semaglutide (1)

Sponsors

AMAG Pharmaceuticals, Inc. (1)  ·  China National Center for Cardiovascular Diseases (1)  ·  Peter Rossing (1)

Countries

Canada (1)  ·  China (1)  ·  Denmark (1)  ·  Germany (1)  ·  Spain (1)  ·  Sweden (1)  ·  United Kingdom (1)  ·  United States (1)

Results publications

PMID 17276178, PMID 18765433, PMID 19414839, PMID 20048204, PMID 28372549, PMID 30675420, PMID 30802204, PMID 31326992, PMID 32223336, PMID 33020228, PMID 33306104, PMID 33394059, PMID 33914608, PMID 34453165, PMID 34660741

NIH funding

2023 (1)